 IV. To describe the pharmacodynamics PD of CBLC502 by examining plasma levels of various cytokines, including filgrastim granulocyte-colony stimulating factor G-CSF, interleukin IL-6, IL-8, IL-10, and tumor necrosis factor-alpha TNF-α. 